Bad boy Shkreli fired from pharma company KaloBios
Add BT as a preferred source
DeeperDive is a beta AI feature. Refer to full articles for the facts.
New York
THE controversial US pharma boss and hedge fund figure Martin Shkreli has been fired as CEO of KaloBios Pharmaceuticals following his arrest on fraud charges, the firm said on Monday.
The news came on the heels of Mr Shkreli's resignation on Friday as boss of Turing Pharmaceuticals, the day after his indictment over allegations of a Ponzi scheme-like fraud conspiracy. Mr Shkreli was "terminated as chief executive officer of the company and resigned from his position as a member of the board of directors" on Dec 17, the day of his arrest, KaloBios said in a securities filing.
Share with us your feedback on BT's products and services
TRENDING NOW
Shelving S$5 billion office redevelopment plan proved ‘wise’ as geopolitical risks mount: OCBC chairman
OCBC is said to emerge as lead bidder for HSBC Indonesia assets
Middle East-linked energy supply shocks put Asean Power Grid back in focus
Eurokars Group introduces rental car franchises Enterprise Rent-A-Car, National Car Rental, and Alamo to Singapore
